Effectiveness of "threshold" in the management of ovarian cancer: A review of the literature

The "Institut national du cancer" has established since 2007 a minimum threshold of 20 patients per year per center to treat patients with gynecologic cancer. This review aims to assess whether the literature data validate this approach, and specifically for ovarian cancer. A search of the...

Full description

Saved in:
Bibliographic Details
Published inBulletin du cancer Vol. 103; no. 6; p. 513
Main Authors Seror, Julien, Guillot, Eugénie, Genin, Anne-Sophie, Hequet, Delphine, Pouget, Nicolas, Dubot, Coraline, Rouzier, Roman
Format Journal Article
LanguageFrench
Published France 01.06.2016
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:The "Institut national du cancer" has established since 2007 a minimum threshold of 20 patients per year per center to treat patients with gynecologic cancer. This review aims to assess whether the literature data validate this approach, and specifically for ovarian cancer. A search of the MEDLINE database was conducted, to reference all relevant articles evaluating one hand the links between the survival of patients with ovarian cancer and the average volume of patients per center and by operator; and secondly the relationship between quality of oncological surgery and these volumes. Nineteen studies met our inclusion criteria; seventeen were retrospective and two were prospective; population samples ranged from 476 to 96,802 patients. The most important data, quantitatively and qualitatively, concern the evaluation of survival based on the average volume per center, with 8 out of 13 studies finding a statistically significant correlation between average volume per center and survival. Data on the quality of surgery are less abundant and more heterogeneous, depending on the definition of the "optimal" surgery by the authors. The establishment of threshold centers appears to be an effective way to improve survival in ovarian cancer. However, these thresholds would have to be specific to ovarian cancer and not extended to "gynecological cancers."
ISSN:1769-6917
DOI:10.1016/j.bulcan.2016.03.010